BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Balance Sheet
USA - NASDAQ:BDRX - US59564R8806 - ADR
5.48 USD
+0.37 (+7.24%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 4.04M | 1.67M | 5.97M | 2.84M | 10.06M | |||
| Cash Equivalents | null | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 4.96M | 715.00K | 704.00K | 1.48M | 1.10M | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | null | 6.43M | 355.00K | 376.00K | 607.00K | |||
| Total Current Assets | 8.99M | 8.81M | 7.03M | 4.69M | 11.76M | |||
| Non-Current Assets | ||||||||
| PPE Net | 187.00K | 324.00K | 571.00K | 831.00K | 1.15M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | 0 | 0 | 0 | 0 | |||
| Intangibles | 5.64M | 5.65M | 2.94M | 6.00K | 0 | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 5.83M | 5.97M | 3.51M | 837.00K | 1.15M | |||
| TOTAL ASSETS | 14.82M | 14.78M | 10.54M | 5.53M | 12.91M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 430.00K | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 501.00K | 179.00K | 169.00K | 161.00K | 146.00K | |||
| Accrued Expenses | null | 1.27M | 857.00K | 817.00K | 546.00K | |||
| Accounts Payable | 1.41M | 707.00K | 1.55M | 339.00K | 485.00K | |||
| Other Current Liabilities | 564.00K | 2.44M | 4.23M | 583.00K | 664.00K | |||
| Total Current Liabilities | 2.48M | 5.03M | 5.57M | 1.90M | 1.84M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 118.00K | 295.00K | 463.00K | 620.00K | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 909.00K | 1.31M | null | 0 | 0 | |||
| Total Non-Current Liabilities | 909.00K | 1.42M | 295.00K | 463.00K | 620.00K | |||
| TOTAL LIABILITIES | 3.39M | 6.46M | 5.86M | 2.36M | 2.46M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -100.24M | -96.53M | -88.31M | -81.61M | -74.08M | |||
| Additional Paid In Capital | 97.73M | 93.12M | 86.73M | 83.67M | 83.43M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 13.94M | 11.72M | 6.25M | 1.11M | 1.10M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 3.00K | null | null | null | 0 | |||
| Shares Outstanding | 1.52M | 163.92K | 1.17K | 5.320381714428462 | 0.07355366425477138 | |||
| Tangible Book Value per Share | 0.0009 | 0.004 | 0.365 | 145.6391 | 4.25K | |||
| Total Shareholders' Equity | 11.44M | 8.32M | 4.68M | 3.16M | 10.45M | |||
| TOTAL LIABILITIES AND EQUITY | 14.82M | 14.78M | 10.54M | 5.53M | 12.91M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.07 | 0.06 | 0.15 | 0.06 | |||
| Current Ratio | 3.63 | 1.75 | 1.26 | 2.47 | 6.39 | |||
| Return On Assets (ROA) | -42.01% | -38.76% | -67.15% | -138.57% | -42.28% | |||
| Return On Equity (ROE) | -54.45% | -68.84% | -151.33% | -242.13% | -52.24% | |||
All data in GBP , ROIC based on taxRate of 0.21